Read and report vaccine reactions, harassment and failures.
Young infants with developing immune systems, as well as older children, adolescents, and adults may be at risk for developing pertussis. Studies have indicated that infants do not appear to receive substantial benefits from maternal antibodies, which may put them at a higher risk of developing pertussis. For many individuals, the pertussis vaccine (DPT, DTaP, TDaP) does not give long lasting protection against the disease and some individuals will never develop temporary immunity despite receiving all recommended boosters. , Over time, the temporary immunity individuals may acquire through vaccination wanes, which often results in outbreaks of B pertussis in fully vaccinated children, teenagers and adults. , , ,
Other populations who may be at risk for developing pertussis include healthcare personnel or persons with weakened immune systems.
IMPORTANT NOTE: NVIC encourages you to become fully informed about Pertussis and the Pertussis vaccine by reading all sections in the Table of Contents , which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.